RLFTY — MindMaze Therapeutics Holding SA

OTC · Health Care · Pharmaceuticals · CIK 1854078 · Switzerland
Last close
$0.42
Market Cap
$66.59M
52W High
$2.40
52W Low
$0.27
ADV30
259
Next earnings
MindMaze Therapeutics Holding SA operates as a commercial-stage biopharmaceutical and neurotechnology company in Asia, the United States, Switzerland, rest of Europe, and internationally. The company offers MindPod system, a supervised in-clinic neurorehabilitation system designed to initiate and intensify the recovery journey; MindMotion GO, which extends protocolized neurotherapeutics into outpatient and home settings; MindMotion Companion, an application that manages prescription, monitoring and documentation across MindMaze Therapeutics' neurotherapeutics ecosystem; and the patient app, a patient-facing mobile application, that supports clinic-to-home continuity by making prescribed therapy easy to follow outside the clinic. It also provides Izar hand therapy device which supports fine motor rehabilitation; Physilog sensor, a wearable inertial sensing device designed to quantify human movement; toaprun, a training for Parkinson's therapy-reimagined through play. The company was founded in 2012 and is headquartered in Geneva, Switzerland.
No quarterly fundamentals indexed for this ticker.

Yahoo Snapshot (yfinance, live)

Total Revenue
$642,000
EBITDA
$-9,143,000
Free Cash Flow
Enterprise Value
Total Cash
Total Debt
Shares Out
157,602,044
Trailing EPS
$-0.60
Book Value
$3.26
ROE
-51.6%
ROA
-25.5%
Div Yield

Annual Trend (SEC EDGAR, last 2y)

Revenues vs Net Income (last 2y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 642,000 -10,515,000 -9,906,000 51,530,000 13,189,000 -7,208,000
Dec 2024 0 -2,000 -1,000 93,000 7,000 -3,000

Peers — same industry

TickerNameMarket CapLastDaily %
CING Cingulate Inc. $65.73M $4.88
BGM BGM Group Ltd. $67.73M $0.38
BYSI BeyondSpring Inc. $64.56M $1.57
CYPH CYPHERPUNK TECHNOLOGIES INC. $69.20M $0.65
PLRX PLIANT THERAPEUTICS, INC. $69.97M $1.13

News headlines (Yahoo Finance, 1h cache)

MindMaze Therapeutics Publishes Invitation to the 2026 Annual General Meeting
2026-06-03 05:00 · Yahoo
MindMaze Therapeutics Announces Non-Core Asset Sale and Organizational Simplification
2026-06-02 05:05 · Yahoo
MindMaze Therapeutics Announces CHF 8.0 Million Strategic Equity Financing
2026-05-26 05:50 · Yahoo
MindMaze Therapeutics and Vibra Healthcare Sign Definitive Channel Partnership Agreement to Scale Advanced Neurotherapeutics Across the U.S.
2026-05-12 05:25 · Yahoo
MindMaze Therapeutics Announces Initiation of Coverage by Baader Bank
2026-03-19 06:35 · Yahoo
MindMaze Therapeutics Appoints HealthTech Veteran Zach Henderson as CEO to Accelerate Global Commercial Scale
2026-03-12 07:44 · Yahoo
MindMaze Therapeutics Provides Corporate Update and Publishes March 2026 Investor Presentation
2026-03-03 07:45 · Yahoo
MindMaze Therapeutics: Consolidating a Global Approach to Reimbursement for Next-Generation Therapeutics
2025-12-23 06:20 · Yahoo
Relief Therapeutics and NeuroX Complete Business Combination and Form MindMaze Therapeutics
2025-12-15 06:20 · Yahoo
Relief Therapeutics Shareholders Approve Business Combination with NeuroX
2025-11-14 17:40 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.